Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations

MC Ryan, EM Shooter, L Notterpek - Neurobiology of disease, 2002 - Elsevier
MC Ryan, EM Shooter, L Notterpek
Neurobiology of disease, 2002Elsevier
Alterations in peripheral myelin protein 22 (PMP22) gene expression are associated with
demyelinating peripheral neuropathies. Overexpression of wild type (wt) PMP22 or inhibition
of proteasomal degradation lead to the formation of aggresomes, intracellular ubiquitinated
PMP22 aggregates. Aggresome formation has now been observed with two mutant
PMP22s, the Tr-and TrJ-PMP22 when the proteasome is inhibited. The formation of these
aggresomes required intact microtubules and involved the recruitment of chaperones …
Alterations in peripheral myelin protein 22 (PMP22) gene expression are associated with demyelinating peripheral neuropathies. Overexpression of wild type (wt) PMP22 or inhibition of proteasomal degradation lead to the formation of aggresomes, intracellular ubiquitinated PMP22 aggregates. Aggresome formation has now been observed with two mutant PMP22s, the Tr- and TrJ-PMP22 when the proteasome is inhibited. The formation of these aggresomes required intact microtubules and involved the recruitment of chaperones, including Hsp40, Hsp70, and αB-crystallin. Spontaneously formed ubiquitinated PMP22 aggregates were also observed in Schwann cells of homozygous TrJ mice. Significant upregulation of both the ubiquitin-proteasomal and lysosomal pathways occurred in affected nerves suggesting that two pathways of PMP22 degradation are present. Thus, the presence of aggresomes appears to be a common finding in neuropathy models of PMP22 overexpression and of some point mutations known to cause neuropathy in mice and humans.
Elsevier